Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma

Jae-Lyun Lee • 15 Mar 2019
GU Cancers 2019
Bladder Cancer Genitourinary Cancer Gemcitabine Oxaliplatin
COACH

Jae-Lyun Lee, MD, of the Asan Medical Center, Seoul, South Korea, speaks about the promising results of gemcitabine-oxaliplatin (GemOx) for advanced urothelial carcinoma (UC) to date, and discusses future directions for the treatment of cisplatin-unfit advanced UC. This video was filmed at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Jae-Lyun Lee

4:21
COACH trial update: GemOx vs. GCb in cisplatin-unfit advanced urothelial carcinoma
Jae-Lyun Lee • 15 Mar 2019

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals